Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX)

CUSIP: 89422G107

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
+984,130
SEC-reported price per share
$58.88
Number of holders
71
Value change
+$59,105,775
Number of buys
49
Number of sells
19
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
94,164,012

Security key

89422G107

Report period

Q3 2026

Institutions

71

Top holders

10

Ownership snapshot

Top reported holders of TVTX - Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Janus Henderson Group Ltd.
Disclosed value leader
Jupiter Topco LLC
Comparable rows
10/15
Latest evidence
30 Jun 2026
13D/G 13F Lead comparable stake: 12% 5 rows are not safely comparable across share classes. 13D/G row: Janus Henderson Group Ltd. Showing 1-6 of 15 holder rows.

Quick read

Janus Henderson Group Ltd. leads the comparable SEC ownership view at 12%.

10 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Janus Henderson Group Ltd.'s linked filing trail.
Comparable ownership Top 5
Janus Henderson Group Ltd. 12%
FMR LLC 7.7%
BlackRock, Inc. 7.5%
BANK OF AMERICA CORP /DE/ 5.8%
VANGUARD CAPITAL MANAGEMENT LLC 5.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Janus Henderson Group Ltd.
13D/G
JANUS HENDERSON GROUP PLC
12%
Reported 13D/G · 30 Sep 2025
$253,331,874
10,599,660 shares
-$17,690,876 30 Sep 2025
FMR LLC
13D/G 13F
Company
7.7%
Reported 13D/G · 30 Jun 2026
$410,549,878
7,142,482 shares
-$196,858,711 30 Jun 2026
BlackRock, Inc.
13F 13D/G
Company
7.5%
Reported 13D/G · 31 Mar 2025
$455,733,539
8,165,419 shares
mixed-class rows
— 30 Jun 2026
BANK OF AMERICA CORP /DE/
13D/G 13F
Company
5.8%
Reported 13D/G · 30 Jun 2026
$312,642,629
5,439,155 shares
$0 30 Jun 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F 13D/G
Company · Vanguard Capital Management
5.1%
Reported 13D/G · 31 Mar 2026
$234,092,574
5,338,582 shares
mixed-class rows
— 30 Jun 2026
PERCEPTIVE ADVISORS LLC
13F 13D/G
Company
4.8%
Reported 13D/G · 31 Dec 2025
$213,183,729
3,752,574 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
71
Shares
4,146,802
Rows available
71
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
318
Q3 2026 holders
71
Holder diff
-247
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .